Navigation Links
Chesson Labs Liquid Bandage Product NUVADERM(TM) Receives FDA 510(k) Market Clearance
Date:8/5/2009

DURHAM, N.C., Aug. 5 /PRNewswire/ -- Chesson Labs today announced receiving 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for NUVADERM(TM), the Company's liquid bandage product. The 510(k) clearance allows Chesson Labs to market and sell the product for use by healthcare professionals and directly to consumers.

The FDA has cleared claims on the product "to cover intact skin and minor cuts, scrapes, burns or irritations of the skin, to help keep them clean and dry and help protect them from infection." The fast application, drying and coverage characteristics make NUVADERM well suited to meet the needs of individuals treating minor wounds. The product also has antimicrobial properties.

NUVADERM's clearance is a significant milestone for Chesson Labs because it is their first medical device submission to the FDA and first 510(k) clearance. The Company anticipates submission of additional filings to the FDA as it continues to expand its product portfolio.

"NUVADERM's clearance is a major milestone for Chesson Labs, but more importantly it is a product developed to improve wound care for individuals treating themselves as well as medical personnel who need a rapid response product to treat minor wounds," said Scott Neuville, President and CEO of Chesson Labs.

ABOUT CHESSON LABS

Chesson Laboratory Associates, Inc. is a privately funded healthcare products company founded in 2006. Chesson Lab's products cleared for market and under development are based on innovative patented and patent-pending polymer-based technology. The mission of Chesson Labs is to improve global healthcare by becoming a market leader in the development and delivery of innovative polymer-based medical products.

Chesson Labs is headquartered in the University Tower in Durham, NC. For more information, visit

SOURCE Chesson Labs
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Dr. Laura Jana Offers Parents Five Key Ways to Ensure Accurate Dosing of Liquid Medication to Infants
2. Capsugels Liquid Dosage Form Technology Utilized by Eight of the Top 10 Pharmaceutical Companies
3. Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation
4. Hot liquids release potentially harmful chemicals in polycarbonate plastic bottles
5. Jefferson neurosurgeons using new liquid treatment for wide-neck brain aneurysm
6. LiquidAgents Healthcare, LLC Awarded Accreditation from the Joint Commission
7. Rutgers center sparks liquid bandage, a new frontline wound treatment
8. Give Vitasoys Liquid Love for Heart Month!
9. AcroMetrix Announces Launch of First Liquid MRSA Positive Control
10. Nature Made(R) Liquid Softgels Help Fuel Oprahs A New Earth Web Event
11. Oracle Healthcare Acquisition Corp. Changes Record Date and Date of Special Meeting to Consider and Vote on Dissolution and Plan of Liquidation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Washington, DC (PRWEB) May 23, 2013 ... announcement (PSA) campaign that empowers parents to talk to ... dangers of underage drinking, was launched today by the ... , The kickoff occurred in conjunction with SAMHSA’s 2013 ... awareness of, and action around, substance abuse and mental ...
(Date:5/23/2013)... Susquehanna Health is now ... babysitting training course for adolescents age 11 and up. ... pediatrician Dr. Patricia Keener after a colleague’s toddler choked ... sitter who didn’t know how to provide first aid. ... a medical basis that aims to reduce the number ...
(Date:5/23/2013)... Live Lead Pros , with its ... business lead solution via its smart solution for ... features Free Web Based Account Management, Database Usage, ... "Automatic Transfer Retry". The company has recently announced ... system. , Its Free Database Usage offers their ...
(Date:5/23/2013)... dragged to its destruction inside a cell, a ... that thwart the development of tumor-suppressing microRNAs (miRNAs) ... online publication at Nature . , Under ... the epidermal growth factor receptor (EGFR) gums up ... by scientists at The University of Texas MD ...
(Date:5/23/2013)... about to be tested in a clinical trial by ... for Alzheimer,s disease has failed to work with the ... according to results of a study by University of ... neuroscience affiliated with the Evelyn F. and William L. ... the importance of verifying promising research results before investing ...
Breaking Medicine News(10 mins):Health News:New Campaign to Help Parents Talk to Younger Children About the Dangers of Underage Drinking 2Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 2Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 3Health News:Live Lead Pros Announces The Benefits of Comprehensive Campaign Delivery and Management System 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 3Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3
... ADMISSION TO ICU MAY INCREASE RISK OF DEATH , ... have an increased risk of death compared with those ... Philadelphia, Philadelphia, PA, and Eastern Virginia Medical School, Norfolk, ... between time of admission to the ICU and mortality, ...
... appear to be associated with increased rates of mood, anxiety ... report in the June issue of Archives of General ... of child maltreatment and later mental health outcomes have relied ... the article. Doubts have been raised about the reliability and ...
... , MONDAY, July 5 (HealthDay News) -- Too much time ... risk of attention problems in children and young adults, new ... to point out the ill effects of excessive screen time, ... Swing, a graduate student at Iowa State University, compared participants ...
... 7 year study ... and weight loss programs. , , ... (PRWEB) July 6, 2010 -- After conducting a 7 year study with over 1,853 ... to other diet programs - the average weight loss was 22.3 pounds compared to 9 ...
... ... , ... 2010 -- Trek Bicycle, the world leader in bicycle technology and innovation, officially launched its ... of the 2010 Tour de France’s Grand Départ, the incendiary new Madone 6 Series SSL ...
... ... under the Oracle Partner Network program. , ... (PRWEB) July 5, 2010 -- TowerStrides Inc ., a professional provider of ... the Oracle PartnerNetwork (OPN). As an Oracle Gold Partner , TowerStrides intends to continue ...
Cached Medicine News:Health News:News briefs from the July issue of Chest 2Health News:Abused children appear likely to have mental disorders as young adults 2Health News:Too Much Screen Time Can Threaten Attention Span 2Health News:Too Much Screen Time Can Threaten Attention Span 3Health News:Trek Introduces All New 2011 Madone Family of Road Bikes 2Health News:Trek Introduces All New 2011 Madone Family of Road Bikes 3Health News:Trek Introduces All New 2011 Madone Family of Road Bikes 4Health News:TowerStrides Inc. Becomes Oracle PartnerNetwork Gold Level Partner 2Health News:TowerStrides Inc. Becomes Oracle PartnerNetwork Gold Level Partner 3
(Date:5/23/2013)... 2013 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... President and Chief Executive Officer of Neurocrine Biosciences, will be ... Health Care Conference in Boston.   The live ... Eastern Time / 8:20 a.m. Pacific Time.  The presentation will ... at http://www.neurocrine.com . If you are ...
(Date:5/23/2013)... 2013 Amgen (NASDAQ: AMGN ) will ... Conference on Thursday, May 30, 2013, at the Westin Boston ... a.m. Eastern Daylight Time. Arvind Sood , ... the conference. Live audio of the presentation can be accessed ... under Investors. A replay of the webcast will also be ...
(Date:5/23/2013)... -- Haemonetics Corporation (NYSE: HAE ) announced today that ... will present at The Deutsche Bank 38 th Annual ... on May 29, 2013 at 1:30pm Eastern time.  ... public may access Mr. Lindop,s presentation live via webcast at: ... Haemonetics (NYSE: HAE ) is a global healthcare ...
Breaking Medicine Technology:
... Phase II Testing Certification with Edifecs CORE Testing Service ... in X12 Version 5010BELLEVUE, Wash., April 5 ... its partners CAQH and Harvard Pilgrim Health Care, examine ... II Certification testing including elements of the newly mandated ...
... SILVER SPRING, Md., April 2 Novo Nordisk today announced ... United States Food and Drug Administration (FDA) has finalized its ... analogue. The Advisory Committee voted on questions related to the ... , A majority ...
Cached Medicine Technology:Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 2Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 3Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 4Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 5Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 2Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 3
... The Hub Cap Limited ... to provide outstanding fixation and ... targeted solution for four corner ... the plate offers the kind ...
... cornerstones of the Acutrak family are the ... Together they are used primarily for secure ... upper extremity, but have been used for ... stabilized with these two systems have ranged ...
... decade KMI® revolutionized the wrist arthroplasty market ... Wrist System. We're at it again, with ... the Universal2. Like the original, the Universal2 ... live with debilitating arthritis. To date, we ...
A straight suture punch with 2.5 mm needle and 2/0 to #1 monofilament suture....
Medicine Products: